Screening for Antimicrobials and Phytochemical and Assessing the Therapeutic Efficacy of the Extracts from The Foliage and Stem Bark of the Designated Medicinal Species Crateva Adansonii Against Multi- Drug Resistant S. Typhi

References

[1] H. Trawinski, S. Wendt, N. Lippmann, S. Heinitz, A. Von Braun, and C. Lübbert, “Typhoid and paratyphoid fever,” Z. Gastroenterol., 2020, 1945.

[2] J. A. Crump and E. D. Mintz, “Global trends in typhoid and paratyphoidfever,” 2010. 10.1086/649541.

[3] M. Hancuh et al., “Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022,” MMWR. Morb. Mortal Wkly. Rep., 2023, 10.15585/mmwr.mm7207a2.

[4] R. S. Chaughule and R. S. Barve, “Role of herbal medicines in the treatment ofinfectious diseases,” Vegetos, 2024, 022-00549-2.Microbiol., vol. 10, no. 02, pp. 46– 57,2020,

[8] F. Mouton, E. I. Ohuoba, F. M. Evans, and I. Desalu, “Typhoid enteric fever – Part 1,” Updat. Anaesth., 2017.

[9] J. Kaur and S. K. Jain, “Role of antigens and virulence factors of Salmonella enterica serovar Typhi in its pathogenesis,” 2012. 10.1016/j.micres.2011.08.001.

[10] N. Mohammed, S. D. Oloninefa, J. E. Aisoni, V. K. Fadayomi, S. Sanusi, and A. Aliyu, “Phytochemical analysis and antibacterial activity of Crateva adansonii DC leaves and stem bark extracts against some pathogenicbacteria,” Sci. World J., vol. 19, no. 2, pp. 403 –408, Jul. 2024,

[11] M. A. Akanji, “Safety Evaluation of Aqueous Extract of Crateva adansonii Leaves on Selected Tissues of Rats,” Fountain J. Nat. Appl. Sci., 2013,

[12] M. S. Nounagnon et al., “PHYTOCHEMISTRY AND BIOLOGICAL ACTIVITIES OF CRATEVA ADANSONII EXTRACTS,” Int. J. Pharm. Pharm. Sci., 2018, 10.22159/ijpps.2018v10i9.27197.

[13] R. Thirumalaisamy, S. Ammashi, and G. Muthusamy, “Screening of anti- inflammatory phytocompounds from Crateva adansonii leaf extracts and its validation by in silico modeling,” J. Genet. Eng. Biotechnol., 2018,

[14] I. Pervaiz et al., “Phytochemical composition, biological propensities, and in-silico studies of Crateva adansonii DC.:A natural source of bioactive compounds,” Food Biosci., vol. 49, p. 101890, Oct. 2022,

[15] Z. F. M. Mignanwandé et al., “Antibacterial Properties of <i>Crateva adansonii</i>(Capparidaceae) on Strains Isolated from Chronic Wounds Diagnosed in the Commune of Ouinhi in 2021,” Pharmacol. & Pharm., 2023, 10.4236/pp.2023.1411029.

[16] A. A. Agboke, A. A. Attama, and M. A. Momoh, “Evaluation of the antimicrobial activities of crude extract of Cryptolepis sanguinolenta and Crateva adansoniileaves and their interactions,” J. Appl.Pharm. Sci., 2011.

[17] K. Ahama-Esseh et al., “Anti- inflammatory activity of Crateva adansonii DC on keratinocytes infected by Staphylococcus aureus: From traditional practice to scientific approach using HPTLC-densitometry,” J. Ethnopharmacol., 2017, 10.1016/j.jep.2017.04.001.

[18] K. Atchou et al., “Antihyperglycaemic and antioxidant activities of Crataeva adansonii DC. ssp. adansonii leavesextract on ICR mice,” J. Drug Deliv. Ther., 2020, 10.22270/jddt.v10i1-s.3855.

[19] A. B. Kakpo, E. Y. Ladekan, F. Gbaguidi, S. Kpoviessi, and J. D. Gbenou,“Ethnopharmacological investigation of medicinal plants used to treat typhoidfever in Benin,” J. Pharmacogn. Phytochem., 2019.

[20] T. V. Dougnon et al., “Traditional treatment of human and animal salmonelloses in Southern Benin: Knowledge of farmers and traditherapists,” Vet. World, 2017, 10.14202/vetworld.2017.580-592.

[21] M. Birkhold, A. Mwisongo, A. J. Pollard, and K. M. Neuzil, “Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas,” J. Infect. Dis., 2021, 10.1093/infdis/jiab449.

@article{1710007,
      author = {Tripti Kashyap, Dr. M K Dwivedi},
      title = {Screening for Antimicrobials and Phytochemical and Assessing the Therapeutic Efficacy of the Extracts from The Foliage and Stem Bark of the Designated Medicinal Species Crateva Adansonii Against Multi- Drug Resistant S. Typhi},
      journal = {Iconic Research And Engineering Journals},
      year = {2025},
      volume = {9},
      number = {2},
      pages = {166-173},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1710007.pdf},
      abstract = {The escalating prevalence of multi-drug resistant (MDR) Salmonella typhi poses a significant threat to public health, particularly in low- and middle- income countries. In response to the dwindling effectiveness of conventional antibiotics, medicinal plants offer a promising alternative due to their rich phytochemical profiles and traditional use inethnomedicine. This review explores the antimicrobial, anti-inflammatory, and immune-modulatory properties of Crateva adansonii, focusing on its foliage and stem bark extracts. Phytochemical analysis reveals the presence of flavonoids, alkaloids, saponins, tannins, and other bioactive compounds known to disrupt bacterial cell walls, inhibit nucleic acid synthesis, and modulate inflammatory responses. Methanolic leaf extracts exhibit potent in-vitro antibacterial activity against MDR S. typhi, with significant zones of inhibition and favorable minimum inhibitory concentrations. While in-vivo and clinical data remain limited, preliminary findings suggest a potential synergistic effect with standard antibiotics and a role in mitigating inflammation-induced complications. The review underscores the therapeutic promise of C. adansonii, advocating for standardized extraction protocols, toxicological evaluations, and well-structured clinical trials to validate its efficacy and safety in typhoid fever management.},
      keywords = {Crateva adansonii, typhoid fever, multidrug-resistantSalmonellatyphi,phytochemicals, antimicrobialactivity, methanolic extract, herbal medicine, anti- inflammatory.},
      month = {August},
  }